Wells Fargo analyst Michael Turrin maintained a Buy rating on WalkMe (WKME – Research Report) today and set a price target of $18.00. The company’s shares closed last Monday at $12.20, close to its 52-week low of $11.40.
According to TipRanks.com, Turrin has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -23.8% and a 23.4% success rate. Turrin covers the Technology sector, focusing on stocks such as Clearwater Analytics Holdings, Zoom Video Communications, and ZoomInfo Technologies.
Currently, the analyst consensus on WalkMe is a Strong Buy with an average price target of $22.25, representing a 68.2% upside. In a report released today, JMP Securities also maintained a Buy rating on the stock with a $28.00 price target.
WalkMe’s market cap is currently $1.02B and has a P/E ratio of -6.70.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
WalkMe Ltd is the defining solution enabling organizations to better realize the value of software investments. It is a cloud-based digital adoption platform, users employees and customers of organizations can navigate websites, SaaS applications, and mobile apps through a digital, GPS-like experience to accomplish any task from simple, online transactions, to complex cross-application software processes, to fully autonomous experiences that require no manual clicks or entries.
Read More on WKME:
- Centessa Pharmaceuticals (CNTA) Gets a Hold Rating from Goldman Sachs
- Morgan Stanley Thinks Talaris Therapeutics’ Stock is Going to Recover
- Instil Bio (TIL) Gets a Hold Rating from Morgan Stanley
- Cerevel Therapeutics Holdings (CERE) Receives a Hold from Goldman Sachs
- BioNTech SE (BNTX) Gets a Hold Rating from Goldman Sachs